A detailed history of First Hawaiian Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Hawaiian Bank holds 10,093 shares of NBIX stock, worth $1.27 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,093
Previous 5,483 84.08%
Holding current value
$1.27 Million
Previous $754,000 54.11%
% of portfolio
0.04%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$114.58 - $153.15 $528,213 - $706,021
4,610 Added 84.08%
10,093 $1.16 Million
Q2 2024

Jul 02, 2024

BUY
$130.86 - $143.19 $41,875 - $45,820
320 Added 6.2%
5,483 $754,000
Q1 2024

Apr 05, 2024

SELL
$130.4 - $143.74 $13,692 - $15,092
-105 Reduced 1.99%
5,163 $712,000
Q4 2023

Jan 08, 2024

BUY
$106.07 - $132.76 $178,727 - $223,700
1,685 Added 47.03%
5,268 $694,000
Q3 2023

Oct 10, 2023

BUY
$94.02 - $117.1 $84,618 - $105,390
900 Added 33.54%
3,583 $403,000
Q2 2023

Jul 06, 2023

SELL
$89.53 - $104.87 $783,387 - $917,612
-8,750 Reduced 76.53%
2,683 $253,000
Q1 2023

Apr 18, 2023

SELL
$94.11 - $123.02 $300,681 - $393,048
-3,195 Reduced 21.84%
11,433 $1.16 Million
Q4 2022

Jan 12, 2023

SELL
$106.72 - $127.06 $69,368 - $82,589
-650 Reduced 4.25%
14,628 $1.75 Million
Q3 2022

Oct 05, 2022

BUY
$92.03 - $107.81 $1,380 - $1,617
15 Added 0.1%
15,278 $1.62 Million
Q2 2022

Jul 22, 2022

BUY
$75.79 - $100.07 $487,708 - $643,950
6,435 Added 72.89%
15,263 $1.49 Million
Q1 2022

Apr 06, 2022

BUY
$72.45 - $94.81 $2,535 - $3,318
35 Added 0.4%
8,828 $827,000
Q4 2021

Jan 12, 2022

BUY
$79.65 - $106.22 $700,362 - $933,992
8,793 New
8,793 $749,000
Q1 2021

Apr 09, 2021

SELL
$87.57 - $119.4 $269,540 - $367,513
-3,078 Closed
0 $0
Q4 2020

Jan 12, 2021

SELL
$86.91 - $108.33 $12,601 - $15,707
-145 Reduced 4.5%
3,078 $295,000
Q3 2020

Oct 06, 2020

BUY
$96.16 - $135.15 $309,923 - $435,588
3,223 New
3,223 $310,000
Q2 2019

Jul 15, 2019

SELL
$72.24 - $91.27 $9,174 - $11,591
-127 Closed
0 $0
Q1 2019

Apr 02, 2019

SELL
$69.31 - $91.53 $16,703 - $22,058
-241 Reduced 65.49%
127 $11,000
Q4 2018

Jan 11, 2019

BUY
$68.32 - $124.36 $3,962 - $7,212
58 Added 18.71%
368 $26,000
Q3 2018

Oct 16, 2018

BUY
$98.88 - $125.85 $30,652 - $39,013
310 New
310 $38,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.